Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference
- Tuesday, April 12, 2022, 7:10
- Environment
- Add a comment
BOONTON, N.J., April 12, 2022 /PRNewswire/ — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced today that two submitted…
About the Author
adminasapcorp has written 41558 stories on this site.